Dysfunctional HDL: from structure-function-relationships to biomarkers (Q38293462)

1 September 2017

1 reference

title

Dysfunctional HDL: from structure-function-relationships to biomarkers (English)

1 reference

1 September 2017

0 references

Arnold von Eckardstein

series ordinal

3

object named as

Arnold von Eckardstein

1 reference

1 September 2017

4

Ulf Landmesser

1 reference

1 September 2017

Meliana Riwanto

1

1 reference

PubMed ID

25522994

1 September 2017

Lucia Rohrer

series ordinal

2

1 reference

1 September 2017

1 January 2015

1 reference

Handbook of experimental pharmacology

1 September 2017

1 reference

1 September 2017

224

1 reference

1 September 2017

337-366

1 reference

Exercise Training in Patients with Chronic Heart Failure Promotes Restoration of High-Density Lipoprotein Functional Properties

1 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Antiinflammatory properties of HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Effects of torcetrapib in patients at high risk for coronary events

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apolipoprotein A-II is inversely associated with risk of future coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Coronary risk factors and plaque morphology in men with coronary disease who died suddenly

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apolipoprotein A-I attenuates palmitate-mediated NF-κB activation by reducing Toll-like receptor-4 recruitment into lipid rafts

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Pathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Major lipids, apolipoproteins, and risk of vascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Antioxidants and atherosclerotic heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Dyslipidemia and inflammation: an evolutionary conserved mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Structural modifications of HDL and functional consequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Combined statin and niacin therapy remodels the high-density lipoprotein proteome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Inflammation, atherosclerosis, and coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Glycation impairs high-density lipoprotein function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL and cardiovascular-disease risk--time for a new approach?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC-MS/MS and probabilistic peptide scoring.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

An abundant dysfunctional apolipoprotein A1 in human atheroma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL remodeling during the acute phase response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL-inflammatory index correlates with poor outcome in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apoptosis in atherosclerosis: beneficial or detrimental?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Endothelial function: a critical determinant in atherosclerosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Endothelial functions of sphingosine-1-phosphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High density lipoprotein structure

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

The emerging roles of PAF acetylhydrolase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Endothelial and antithrombotic actions of HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

A tale of coronary artery disease and myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL and adaptive immunity: a tale of lipid rafts

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Long-Term Treatment with the Apolipoprotein A1 Mimetic Peptide Increases Antioxidants and Vascular Repair in Type I Diabetic Rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-throughput generation of selected reaction-monitoring assays for proteins and proteomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Molecular regulation of HDL metabolism and function: implications for novel therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Atherosclerosis — An Inflammatory Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apoptosis in the vascular wall and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Antiinflammatory actions of HDL: a new insight

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Effects of dalcetrapib in patients with a recent acute coronary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Variation in paraoxonase-1 activity and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Lipoproteins Containing Apolipoprotein A-IV but Not Apolipoprotein A-I Take Up and Esterify Cell-Derived Cholesterol in Plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apolipoprotein A-IV inhibits experimental colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Role of oxidized low density lipoprotein in atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_10

10.1007/978-3-319-09665-0_10

31 March 2020

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25522994